These are some of this Friday’s top analyst calls with upgrades, downgrades, and initiations seen in Wall Street research notes: American Eagle Outfitters, Inc. (NYSE: AEO) Raised to Buy at Jefferies. Bristol-Myers…
Today’s edition of the BioHealth Business Daily is going to be very cancer-dominated due to the American Society of Clinical Oncology (ASCO) 2010 meeting that started this last weekend. There are many…
We have several big movers on news this morning, and none appear to be based upon earnings. Stocks on the move are ArQule Inc. (NASDAQ: ARQL), BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), Bristol-Myers…
These are some of the major research calls we have seen from analysts in their upgrades, downgrades, and initiations so far this Monday: Amazon.com, Inc. (NASDAQ: AMZN) Raised to Conviction Buy List…
The pharmaceutical industry has found a growing source of sales–the prescription of medicines, primarily used by adults in the past, to children. A portion of the sharp increase in drugs used by…
A look at the “hardest working” major brands for 2009 shows that a number of them belong to companies which have done poorly and, in at least one case, may file Chapter…
Reuters: The Senate overcame opposition to allow jobless benefits to be extended. Reuters: China will hope to keep the value of the yuan steady. Reuters: JC Penney (JCP) will focus on exclusive…
There are twelve major pharmaceutical firms that dominate this industry worldwide. Their combined market value is over $1 trillion with total annual sales of over $500 billion. The firms have developed and marketed most…
Short sellers sharply increased their bets against two of America’s most widely followed stocks. Shares sold short in Citigroup (NYSE:C) rose 36% to 381 million. The short interest in Apple (NASDAQ:AAPL) |…
These are this Monday’s top day trader and active trader alert stocks with a link through to each story at VSInvestor.com for more detailed data and analysis: Chattem Inc. (NASDAQ: CHTT) is…
This might have seemed a tough week to come up with a list of unusual suspects. There are only a handful of earnings, but there are many follow-on items from last week…
Bristol-Myers Squibb Co. (NYSE: BMY) has been a real pest in the world of analyzing options trading activity. There has been a perpetual open interest alert with a monster contract volume in…
Douglas A. McIntyre The second half of December is supposed to be when trading volume starts slowing down. That does not look to be the case for this coming week, and this list of the unusual suspects is…
The FDA is routinely criticized for being a poor steward of drug research and pharmaceutical side effects. The agency proved once again why much of the criticism is justified. The FDA today said…
Bristol-Myers Squibb Company (NYSE: BMY) is going to completely separate itself from its holdings in Mead Johnson Nutrition Company (NYSE: MJN). The company expects that the split-off will be a tax-advantaged way…
Douglas A. McIntyre 
